Guiding vacuum-assisted biopsy in prone position: digital breast tomosynthesis vs stereotactic

Author:

Scaperrotta Gianfranco P.1ORCID,Boffelli Giulia2ORCID,Depretto Catherine1,Di Leo Giovanni3,Liguori Alessandro4ORCID,Monaco Cristian Giuseppe3,Anna Borelli5,Ferranti Claudio1

Affiliation:

1. IRCCS Istituto Nazionale dei Tumori, Italy

2. ASST Papa Giovanni XXXIII, Bergamo, Italy

3. IRCCS Policlinico San Donato, Italy

4. Policlinico di Milano, Italy

5. Università degli Studi di Milano, Italy

Abstract

Purpose: To compare the performance of prone digital breast tomosynthesis (DBT)–vacuum-assisted biopsy (VAB) with prone stereotactic-guided VAB (sVAB), focusing on time of procedure, number of expositions, average glandular dose, and complications. Methods: The institutional review board approved this retrospective study and informed consent was waived. From July 2015 to January 2017, 306 patients with 306 suspicious mammographic findings (BI-RADS ⩾4) underwent mammography-guided biopsy, prone sVAB, or prone DBT-VAB. Student t test, chi-square, and multivariate regression statistics were used. Results: During the study period, 155 prone sVAB procedures in 155 patients (mean age, 56 years; age range, 39–84 years) and 151 DBT-VABs in 151 patients (mean age, 57 years; age range, 33–84 years) were performed. Mean procedure time was shorter with DBT-VAB versus sVAB (14.5 versus 17.4 minutes, respectively; p < 0.001), and fewer images were acquired with DBT-VAB versus sVAB (8 vs 11, respectively; p < 0.001); the average glandular dose was significantly lower in DBT-VAB versus sVAB (11.8 mGy versus 18 mGy, respectively; p < 0.001). There were no differences in the distribution of histologic results ( p = 0.74) or breast density ( p = 0.09) between the two groups. No major complications were observed in either group. Conclusion: Performance of prone DBT-VAB was superior to prone sVAB because it allowed a faster procedure with fewer radiologic expositions and lower radiation dose.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3